Skip to main content

Table 2 Major drugs recognized via use of the L1000FWD database

From: Potential prognostic value of a eight ferroptosis-related lncRNAs model and the correlative immune activity in oral squamous cell carcinoma

Rank

Drug

Similarity Score

P-value

Q-value

Z-score

Combined Score

MOA

1

KM-03949SC

-0.4907

1.23e-66

1.06e-62

1.80

-118.88

MEK inhibitor

2

RJC-00245SC

-0.4352

1.37e-53

1.15e-50

1.73

-91.41

estrogen receptor agonist

3

BRD-K82185908

-0.4352

1.99e-51

1.29e-48

1.75

-88.74

adrenergic receptor antagonist

4

KM-00519SC

-0.4259

3.78e-52

2.53e-49

1.72

-88.55

RAF inhibitor

5

BRD-K94987138

-0.4167

6.71e-51

3.99e-48

1.73

-86.64

histamine receptor antagonist

6

BRD-K67619794

-0.4074

3.33e-49

1.53e-46

1.85

-89.77

histamine receptor antagonist

7

BRD-K05197617

-0.4074

5.57e-49

2.46e-46

1.73

-83.71

EGFR inhibitor

8

Ivermectin

-0.3611

7.32e-40

1.20e-37

1.87

-73.29

benzodiazepine receptor agonist

9

Vemurafenib

-0.3426

1.96e-36

2.20e-34

1.81

-64.68

RAF inhibitor

10

BRD-K03122949

-0.3426

1.44e-36

1.64e-34

1.74

-62.28

dopamine receptor antagonist